Dunn, Gavin P.

Cancer immunoediting: from immunosurveillance to tumor escape

Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 5,393

The Somatic Genomic Landscape of Glioblastoma

Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell

Glioma Diagnosis and TreatmentCancer Genomics and Diagnostics

Cited by 5,016

Interferons, immunity and cancer immunoediting

Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology

interferon and immune responsesImmunotherapy and Immune Responses

Cited by 1,617

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine

Immunotherapy and Immune Responsesinterferon and immune responses

Cited by 1,081

Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM

Wiedemeyer, W. R., Dunn, I. F., Quayle, S. N., Zhang, J., Chheda, M. G., Dunn, G. P., Zhuang, L., Rosenbluh, J., Chen, S., Xiao, Y., et al. (2010) · Proceedings of the National Academy of Sciences

Glioma Diagnosis and TreatmentCancer Genomics and Diagnostics

Cited by 223

Glioblastoma-Infiltrating CD8 + T Cells Are Predominantly a Clonally Expanded GZMK + Effector Population

Wang, A. Z., Mashimo, B. L., Schaettler, M. O., Sherpa, N. D., Leavitt, L. A., Livingstone, A. J., Khan, S. M., Li, M., Anzaldua-Campos, M. I., Bradley, J. D., et al. (2024) · Cancer Discovery

Cancer Immunotherapy and BiomarkersGlioma Diagnosis and Treatment

Cited by 73

A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma

Huang, J., Campian, J. L., DeWees, T. A., Skrott, Z., Mistrik, M., Johanns, T. M., Ansstas, G., Butt, O., Leuthardt, E., Dunn, G. P., et al. (2024) · International Journal of Radiation Oncology*Biology*Physics

Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy

Cited by 34

Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas

Mudianto, T., Campbell, K. M., Webb, J., Zolkind, P., Skidmore, Z. L., Riley, R., Barnell, E. K., Ozgenc, I., Giri, T., Dunn, G. P., et al. (2021) · Clinical Cancer Research

Hippo pathway signaling and YAP/TAZMelanoma and MAPK Pathways

Cited by 33